Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women

Menopause

Volumn 8, Issue 6, 2001, Pages 408-419

  Bhavnani, Bhagu R ^a   Cecutti, Anthony ^a   Gerulath, Alan ^a   Woolever, Allan C ^a   Berco, Mauricio ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Atherosclerosis; Cardiovascular diseases; Estrogen replacement therapy; Hormone replacement therapy; Oxidized low density lipoproteins; Postmenopausal women; Red wine; Ring B unsaturated estrogens; Vitamin E

Indexed keywords

17ALPHA ESTRADIOL; 17BETA DIHYDROEQUILENIN; ALPHA TOCOPHEROL; CONJUGATED ESTROGEN; DIHYDROEQUILIN; ESTRADIOL; MEDROXYPROGESTERONE ACETATE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROBUCOL; PROGESTERONE; QUERCETIN; RESVERATROL; TROLOX C; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ESTROGEN THERAPY; FEMALE; HEART PROTECTION; HUMAN; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; POSTMENOPAUSE; WINE;

EID: 0035201910     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-200111000-00005     Document Type: Conference Paper

References (58)

1. Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham population
2. Epidemiology and risk factors for coronary heart disease in women
3. Preserving cardiovascular benefits of hormone replacement therapy
4. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
5. Estrogen and coronary heart disease in women
6. Hormone therapy to prevent disease and prolong life in postmenopausal women
7. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women
8. Hormone replacement therapy, heart disease, and other considerations
9. The pathogenesis of atherosclerosis: An update
10. Koch's postulates for cholesterol
11. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
12. Beyond cholesterol: Modifications of low-density lipoprotein that increases its atherogenicity
13. Antioxidant potential of specific estrogens on lipid peroxidation
14. Oestrogen and inhibition of low density lipoproteins in postmenopausal women
15. Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low density lipoproteins
16. 17Beta-estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages
17. Biologic effects of delta-8-estrone sulfate in postmenopausal women
18. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine
19. Wine, beer, and mortality in middle-aged men from eastern France
20. Inhibition of oxidation of human low density lipoprotein by phenolic substances in red wine
21. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low density lipoproteins
22. Effect of oral supplementation with D-Δ-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation
23. Correlations of vitamin A and E intakes with plasma concentrations of carotenoids and tocopherols among American men and women
24. Vitamin E consumption and the risk of coronary heart disease in men
25. Probucol: A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia
26. Pharmacokinetics and pharmacodynamics of a novel estrogen delta-8-estrone in postmenopausal women and men
27. Improved measurement of low-density lipoprotein susceptibility to copper-induced oxidation: Application of a short procedure for isolating low density lipoprotein
28. Single vertical spin density gradient ultracentrifugation
29. Dialysis of isolated low density lipoprotein induces a loss of lipophilic antioxidants and increases the susceptibility and oxidation in vitro
30. LDL oxidation and extent of coronary artherosclerosis
31. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding
32. Continuous monitoring of in vitro oxidation of human low density lipoprotein
33. Oxidized LDL may play a role in neuronal cell death in Alzheimer's disease
34. Differential ability of cells to promote oxidation of low density lipoproteins in vitro
35. Electrophoretic separation of plasma lipoproteins in agarose gel
36. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
37. Effect of 17β-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus
38. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women
39. Effects of combined estrogen and progestin therapy in postmenopausal women on endothelium levels and oxidation of LDL
40. Oestrogens inhibit copper and cell-mediated modification of low density lipoproteins
41. The inhibition of low-density lipoprotein oxidation by 17β-estradiol
42. The effect of various estrogens and progestogens on the susceptibility of low density lipoproteins to oxidation in vitro
43. Interaction of equine estrogens with estrogen receptors of human and rat uterus
44. Comparison of pharmacokinetics of a conjugated equine estrogen preparation (Premarin) and a synthetic mixture of estrogens (C.E.S.) in postmenopausal women
45. Resveratrol: A molecule whose time has come? And gone?
46. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor
47. Vitamin E consumption and the risk of coronary disease in women
48. Flavonoids inhibit the oxidative modification of low-density lipoproteins by macrophages
49. Probucol prevents the progression of atherosclerosis in Watanobe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia
50. Mechanisms of cardioprotection by estrogens
51. Role of oxidized low-density lipoprotein in atherogenesis
52. Antioxidant protection of LDL by physiological concentrations of 17β-estradiol: Requirement for estradiol modification
53. Association of estrogens with human plasma lipoproteins: Studies using estradiol-17β, and its hydrophobic derivative
54. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
55. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors
56. HDL, its enzymes and its potential to influence lipid peroxidation
57. Protective effect of estrogens and catechol estrogens against peroxidative membrane damage in vitro
58. Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: Chemistry and metabolism